Victory Capital Management
ONCE

Victory Capital Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Victory Capital Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,120
Closed -$690K – 3722
2019
Q3 		$690K Buy
+7,120
New +$713K ﹤0.01% 1786
2018
Q2 		– Sell
-394
Closed -$26K – 1877
2018
Q1 		$26K Hold
394
– – ﹤0.01% 1781
2017
Q4 		$20K Sell
394
-335,050
-100% -$24.1M ﹤0.01% 1788
2017
Q3 		$29.9M Sell
335,444
-81,966
-20% -$6.22M 0.07% 469
2017
Q2 		$24.9M Buy
417,410
+4,750
+1% +$265K 0.06% 519
2017
Q1 		$22M Buy
412,660
+42,388
+11% +$2.52M 0.05% 562
2016
Q4 		$18.5M Sell
370,272
-100,770
-21% -$5.4M 0.05% 586
2016
Q3 		$28.3M Buy
+471,042
New +$27.2M 0.08% 447

Victory Capital Management's ONCE Position: Q4 2019 in Review

Victory Capital Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 7,120 shares — an estimated $690K sold.

Victory Capital Management first reported a position in ONCE in Q3 2016 and held it in 8 quarters. The position peaked at $29.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Victory Capital Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Victory Capital Management sold 7,120 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $690K.
  • Victory Capital Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2016 and held it in 8 quarters.
  • Victory Capital Management's Spark Therapeutics, Inc. Common Stock position peaked at $29.9M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Victory Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.